Navigation Links
The cormorant -- the 'black plague' or an example of successful species conservation?
Date:6/4/2008

d but simply put forward as objections and this was clear to all of those present at the meetings." The Convention on Migratory Species (CMS) clearly stated the fact that the cormorant population is sufficiently stable at the moment and therefore does not have to be regulated, as this convention concentrates first and foremost on highly endangered species.

The researchers have therefore come up with a five-step action plan, which could help to steer the cormorant management in the European Union out of the dead end. Firstly it is necessary to obtain accurate data on cormorant population, as the estimated numbers are varying according to the respective interests. Subsequently, regional conditions would be compared, a cost-benefit analysis of management options conducted, and a common model of the entire cormorant population established. Following this, a comprehensive institution would have to be set up, which would be responsible for the application of a common management strategy in the long run. "These steps must be taken successively. If one was to start with the third step only to discover that no consensus prevails concerning the first step, then everything would fizzle out again." A difficult process, requiring mutual understanding, as all countries would have to give up their decision-making autonomy.

The fact that a trans-national cormorant management policy is however possible can be illustrated by the example of the USA where a central authority is responsible, namely the U.S. Fish and Wildlife Service in the Ministry of the Interior. The problem in North America is comparable with Europe: Since the 1970's, populations of the Double-crested Cormorants of North America (Phalacrocorax auritus) have been increasing. Breeding and wintering areas are distributed over the entire continent and therefore over different Federal States. After an intensive consultation process, a management plan with over 200 pages was compiled in 2003, which is
'/>"/>

Contact: Tilo Arnhold
presse@ufz.de
49-341-235-1635
Helmholtz Association of German Research Centres
Source:Eurekalert  

Page: 1 2 3 4 5

Related biology news :

1. BIO-key(R) Showcasing Public Safety Solutions for BlackBerry Smartphones at 2008 LEIM Conference
2. Wiley-Blackwell to launch Journal of Flood Risk Management
3. Black carbon pollution emerges as major player in global warming
4. NOAA proposes federal regulations to protect black abalone
5. University of Minnesota study refutes belief that black men have more aggressive prostate cancer
6. American Society for Microbiology honors Jason T. Blackard
7. Coal and black liquor can produce energy from papermaking
8. Risk of common vaginal infection linked to preterm birth appears higher for blacks
9. Plague of kangaroos threatens one of Australias last remaining original native grasslands
10. Scientists discover why plague is so lethal
11. Model successfully predicts large river system fish diversity
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
The cormorant -- the 'black plague' or an example of successful species conservation?
(Date:7/9/2015)... 2015  Unchained Labs just can,t get enough ... Avid Nano. Avid Nano designs, develops and manufactures ... Also today, Unchained Labs UNcaged the ... use protein sizing system. The pUNk is a ... size, size distribution, aggregation population and molecular weight. ...
(Date:7/8/2015)... July 8, 2015  Trovagene, Inc. (NASDAQ: ... today announced the launch of a study that ... Cancer Monitoring℠ (PCM) technology for predicting response to ... a combination of the novel immunotherapy agents Yervoy® ... PD-1 inhibitor. The 50-patient study will be led ...
(Date:7/7/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... commerce market announces a revised version of one of its first ... air on CNBC in New York , ... San Francisco metro areas.    ... ability to replace all the cards in your wallet and keep ...
Breaking Biology News(10 mins):Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3
... body's natural immune responses could be a target of future cancer ... of Medicine of the University of Southern California. , The ... of Pathology, is the first to identify how EphB4 ?a protein ... important aspect of this study is that ?if we turn the ...
... uncovered a new cellular secret that may explain how ... cancers that makes treatment especially difficult. If the mechanism ... can be understood well enough to manipulate it, new ... metastatic cancers. , Significance of the Mayo Clinic ...
... potentially powerful new therapy for treating diabetes, peripheral vascular ... and into animals by demonstrating it restores nerve and ... particularly important implications for the estimated 21 million Americans ... blood vessels. , The therapy involves netrins, a family ...
Cached Biology News:USC researchers investigate protein that protects tumors 2Mayo Clinic researchers discover cancer cells may move via wave stimulation 2Mayo Clinic researchers discover cancer cells may move via wave stimulation 3Proteins spur diabetic mice models to grow blood vessels, nerves 2
(Date:7/27/2015)... July 27, 2015 According to the ... (Home-brew Media, Pre-formulated Media), by Application (Biobanking, Regenerative Medicine, Drug ... Europe , Asia-Pacific , Rest ... global biopreservation media market was valued at $247.7 million in ... by 2019, at a CAGR of 18.2% between 2014 and ...
(Date:7/27/2015)... , July 27, 2015 IDEXX Laboratories, Inc. ... 8,000 clinics have submitted over 100,000 specimens to IDEXX ... just the first 10 days since the breakthrough kidney ... (CKD) is a leading cause of suffering and death ... specimens are consistent with generally accepted kidney disease prevalence ...
(Date:7/25/2015)... ... , ... Technology leader Anton Paar offers the Abbemat ... temperature of the measuring prism. This is required to achieve the most precise ... key requirements. It is likely that no refractometer manufacturers on the market can ...
(Date:7/24/2015)... -- Equity Research Institute has initiated coverage ... PDLI ), Arena Pharmaceuticals Inc. (NASDAQ: ARNA ), ... (NASDAQ: NWBO ), and Acorda Therapeutics Inc. (NASDAQ: ... can be accessed at https://www.EquityResearchInstitute.com/reports?keyword=PDLI On Thursday, ... down 0.49%, the Dow Jones Industrial Average declined 0.67%, ...
Breaking Biology Technology:Global Biopreservation Media Market to be Worth $571.5 Million by 2019 2Global Biopreservation Media Market to be Worth $571.5 Million by 2019 3Over 100,000 Pets Tested with New IDEXX SDMA Kidney Function Test Since Product Launch on July 13 2Over 100,000 Pets Tested with New IDEXX SDMA Kidney Function Test Since Product Launch on July 13 3Over 100,000 Pets Tested with New IDEXX SDMA Kidney Function Test Since Product Launch on July 13 4Over 100,000 Pets Tested with New IDEXX SDMA Kidney Function Test Since Product Launch on July 13 5It’s T-Time for Refractometers: On-site Temperature Check Now Available 2Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 2Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 3Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 4Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 5
... , Revamilast is a PDE4 inhibitor, under development for ... successfully completed pre-clinical trials and Phase I studies , Phase ... UK , , Glenmark has initiated global  Phase IIb ... unmet medical need as globally they are over 300 million Asthma ...
... QinetiQ North America today announced the results of its ... experiment, which studied the effects of microgravity on host ... results of this experiment showed both the plants and ... (Biological Research In a Canister) homes on the shuttle. ...
... Bharat Renewable Energy Ltd (BREL) , a joint-venture of ... a program with SG Biofuels (SGB) to ... production of biodiesel in India. The program,s ... high performing hybrid varieties of Jatropha adapted to unique ...
Cached Biology Technology:Glenmark Initiates Phase IIb Human Trials Globally for its Novel Molecule 'Revamilast' 2Glenmark Initiates Phase IIb Human Trials Globally for its Novel Molecule 'Revamilast' 3Glenmark Initiates Phase IIb Human Trials Globally for its Novel Molecule 'Revamilast' 4QinetiQ North America Gains New Insights into Plant Growth and Sustainable Life Support on Final Shuttle Flight 2Bharat Renewable Energy Forms Alliance With SG Biofuels to Deploy Jatropha Hybrids for Biodiesel in India 2